Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide/Dexamethasone vs Melphalan/Prednisone in Newly Diagnosed Multiple Myeloma
NCT00205751Phase 3Completed
- Sponsor
- Austrian Forum Against Cancer
- Start
- Aug 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide in multiple myeloma (MM), sponsored by Austrian Forum Against Cancer. Started Aug 2001; status: completed.
02
Drugs
thalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00205751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00205751.